NNW Headlines
Save 20% on Press Releases and More with NNW Prime! Click to View Details
Home » LD Micro Main Event » Page 7

Category: LD Micro Main Event

WednesdayDec 11, 2019 12:20 pm

WELL Health Technologies Corp. (TSXV: WELL) (WLYYF) Starts Presentation at 12th Annual LD Micro Main Event

WELL Health Technologies (TSX.V: WELL) (OTC: WLYYF) operates primary healthcare facilities, as well as a significant Electronic Medical Records (“EMR”) business that supports the digitization of such clinics. WELL wholly owns and operates 20 medical clinics and provides digital EMR software and services to 852 medical clinics across Canada. WELL's overarching objective is to empower doctors to provide the best and most advanced care possible by leveraging the latest trends in digital health. WELL was recognized as a TSX Venture 50 Company in 2018 and 2019. For more information, visit the company’s website at www.well.company. About NetworkNewsWire NetworkNewsWire (NNW) is…

Continue Reading

WednesdayDec 11, 2019 12:20 pm

Finjan Holdings Inc. (NASDAQ: FNJN) Starts Presentation at 12th Annual LD Micro Main Event

Finjan (NASDAQ: FNJN) is a globally recognized leader in cybersecurity. Finjan’s inventions are embedded within a strong portfolio of patents focusing on software and hardware technologies used to proactively detect previously unknown and emerging threats on a real-time, behavior-based basis. Finjan continues to grow through investments in innovation, strategic acquisitions, and partnerships promoting economic advancement and job creation. For more information, visit the company’s website at www.finjan.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media…

Continue Reading

WednesdayDec 11, 2019 12:20 pm

Nephros Inc. (NASDAQ: NEPH) Starts Presentation at 12th Annual LD Micro Main Event

Nephros (NASDAQ: NEPH) is a commercial-stage company that develops and sells high performance water purification products to the medical device and commercial markets. Nephros ultrafilters are used in hospitals and medical clinics for added protection in retaining bacteria (e.g., Legionella, Pseudomonas) and viruses from water, providing barriers that assist in improving infection control in showers, sinks, and ice machines. Additionally, Nephros ultrafilters are used by dialysis centers for assisting in the added removal of endotoxins and other biological contaminants from the water and bicarbonate concentrate supplied to hemodialysis machines and patients. For more information, visit the company’s website at www.nephros.com.…

Continue Reading

WednesdayDec 11, 2019 12:00 pm

Aytu BioScience Inc. (NASDAQ: AYTU) Starts Presentation at 12th Annual LD Micro Main Event

Aytu BioScience (NASDAQ: AYTU) is committed to better health for men, women, and children here at home and worldwide. An emerging specialty pharmaceutical company, Atyu is focused on commercializing novel products that address significant patient needs. The company is dedicated to better health and better living for patients. By acquiring or licensing approved, commercialized products and late-stage development therapeutics, we bring novel and needed treatments to market and to the millions of patients that need them. Novel products that can really help people feel better—and these products can make an impact today on patients’ health and well-being. For more information,…

Continue Reading

WednesdayDec 11, 2019 12:00 pm

SELLAS Life Sciences Group Inc. (NASDAQ: SLS) Starts Presentation at 12th Annual LD Micro Main Event

SELLAS Life Sciences (NASDAQ: SLS) is a late-stage biopharmaceutical company focused on the development of novel cancer immunotherapies for a broad range of cancer indications. The company’s lead product candidate, galinpepimut-S, is a cancer immunotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center that targets a broad spectrum of hematologic cancers and solid tumor indications. Galinpepimut-S is poised to enter pivotal Phase 3 clinical trials, pending funding availability, in patients with AML and mesothelioma. For more information, visit the company’s website at www.seedolab.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and…

Continue Reading

WednesdayDec 11, 2019 12:00 pm

WidePoint Corp. (NYSE: WYY) Starts Presentation at 12th Annual LD Micro Main Event

WidePoint (NYSE : WYY) is a provider of Trusted Mobility Management (“TM2”) solutions, specializing in telecommunications management, mobile management, identity management, and digital billing and analytics solutions. WidePoint has a diverse portfolio of government and commercial clients, serving global and international enterprises and the Fortune 100 across a multitude of industries. For more information, visit the company’s website at www.widepoint.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a…

Continue Reading

WednesdayDec 11, 2019 12:00 pm

Orion Energy Systems Inc. (NASDAQ: OESX) Starts Presentation at 12th Annual LD Micro Main Event

Orion (NASDAQ: OESX) is a leader in LED lighting systems which transform commercial and industrial buildings into state-of-the-art, energy-efficient facilities. Orion is a U.S.-based manufacturer and is proud to claim Made in the USA on its products. The company’s product portfolio includes LED products covering industrial, commercial, agricultural, exterior and lighting control applications. Many of Orion's nearly 100 granted patents relate to lighting systems that provide exceptional optical and thermal performance, driving financial, environmental and work-space benefits for a wide variety of customers in the retrofit category. For more information, visit the company’s website at www.orionlighting.com. About NetworkNewsWire NetworkNewsWire (NNW)…

Continue Reading

WednesdayDec 11, 2019 12:00 pm

Simulations Plus Inc. (NASDAQ: SLP) Starts Presentation at 12th Annual LD Micro Main Event

Simulations Plus (NASDAQ: SLP) is a leading developer of Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) modeling, physiologically based pharmacokinetic (PBPK) & physiologically based biopharmaceutics (PBBM) modeling and simulation software for the pharmaceutical and biotechnology, industrial chemical, cosmetic, herbicide and food ingredient industries today. The company’s software allows pharmaceutical scientists to predict certain key potential endpoints and dynamics, in silico, thereby reducing research and development costs and helping clients make better projects decisions sooner. For more information, visit the company’s website at www.simulations-plus.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and…

Continue Reading

WednesdayDec 11, 2019 11:40 am

Converge Technology Solutions Corp. (CTSDF) Starts Presentation at 12th Annual LD Micro Main Event

Converge Technology Solutions (OTCQX: CTSDF) combines innovation accelerators and foundational infrastructure solutions to deliver best-of-breed solutions and services to customers. The company is building a platform of regionally-focused Hybrid IT solution providers to enhance their ability to provide multi-cloud solutions, blockchain, resiliency, and managed services, enabling Converge to address the business and IT issues that public and private-sector organizations face today. For more information, visit the company’s website at www.convergetp.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services,…

Continue Reading

WednesdayDec 11, 2019 11:40 am

Intec Pharma Ltd. (NASDAQ: NTEC) Starts Presentation at 12th Annual LD Micro Main Event

Intec Pharma (NASDAQ: NTEC) is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The company's Accordion Pill is an oral drug delivery system designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and specific release mechanism. In addition, the company has a feasibility agreement for the development of a custom-designed Accordion Pill for a proprietary compound with Novartis Pharmaceuticals and a research collaboration with Merck & Co. For more information, visit the company’s website at www.intecpharma.com. About NetworkNewsWire NetworkNewsWire (NNW) is…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000

NetworkNewsWire

1108 Lavaca St
Suite 110-NNW
Austin, TX 78701
(512) 354-7000

Copyright . NetworkNewsWire® / 1108 Lavaca St Suite 110-NNW Austin, TX 78701 (512) 354-7000 / Disclaimers